Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
6 studies found for:    AD02 Alzheimer's

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
AD02 Alzheimer's
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Biological: AFFITOPE AD02
2 Completed Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: active: AFFITOPE AD02;   Biological: control: Placebo
3 Completed Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02
Condition: Alzheimer's Disease
Intervention: Biological: AFFITOPE AD02
4 Terminated Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006
Condition: Alzheimer´s Disease
Interventions: Biological: AFFITOPE® AD02;   Biological: Placebo
5 Completed Long-term Safety and Tolerability of AFFITOPE AD02
Condition: Alzheimer's Disease
Intervention:
6 Terminated Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease
Condition: Alzheimer´s Disease
Intervention:
To Top

† Indicates status has not been verified in more than two years